Euros for Doctors

Since 2016, the 54 biggest pharma companies in Germany have published their payments to doctors and other health care professionals and organisations from the previous year.

Read the article

Only around a quarter of doctors and health care professionals agreed to the publication of their fees and conference and travel expenses.

Detailed payments to doctors related to studies and non-interventional studies are not published by the pharma companies.

Easd agreed to the publication of these payments:

Company Payment type
Total €2,950,963.20 €1,303,048.35
Boehringer Ingelheim Pharma GmbH & Co. KG/ Boehringer Ingelheim GmbH/ C.H. Boehringer Sohn AG & Co.KG sponsorship €358,165.00
MSD SHARP & DOHME GmbH donations and grants €342,955.47 €352,888.33
Novo Nordisk Pharma GmbH registration fees €568,295.00 €290,755.00
Novartis Pharma GmbH sponsorship €230,936.40 €155,075.00
Lilly Pharma Holding GmbH sponsorship €200,000.00 €38,000.00
Amgen GmbH sponsorship €39,500.00 €32,500.00
Lilly Pharma Holding GmbH donations and grants €23,000.00 €23,000.00
Sanofi-Aventis Deutschland GmbH sponsorship
to: Study of Diabetes
€20,724.82
Janssen-Cilag GmbH donations and grants €20,000.00
Novo Nordisk Pharma GmbH sponsorship €10,000.00
Novo Nordisk Pharma GmbH fees €10,000.00 €820.00
AstraZeneca GmbH registration fees €600.00
Sanofi-Aventis Deutschland GmbH related expenses
to: Study of Diabetes
€520.20
Astellas Pharma GmbH sponsorship €99,705.00
Boehringer Ingelheim Pharma GmbH & Co. KG/ Boehringer Ingelheim GmbH/ C.H. Boehringer Sohn AG & Co.KG sponsorship
to: EASD
€370,229.00
MERCK KGaA/Merck Serono GmbH//Allergopharma GmbH & Co. KG sponsorship €613.49
MSD SHARP & DOHME GmbH sponsorship €300,118.84
Novo Nordisk Pharma GmbH donations and grants €310,000.00
Sanofi-Aventis Deutschland GmbH donations and grants
to: Europ. Ass. For The Study Of Diabet
€4,000.00
Sanofi-Aventis Deutschland GmbH sponsorship
to: Europ. Ass. For The Study Of Diabet
€451,610.00

The information on this page come from the 54 member companies of “Voluntary Self-Regulation of the pharmaceutical industry” (“Freiwilligen Selbstkontrolle für die Arzneimittelindustrie e.V.”) who published these payments on their websites.

Continue searching

More organisations and doctors at similar address

More doctors and organisations nearby

Efsd Rheindorfer Weg 3 €37,500.00
Ellen van Sambeck Rheindorfer Weg 2 €819.41
DRK Deutsches Rotes Kreuz Kölner Landstr. 169 €710.00
bsh medical communications GmbH Liebfrauenstr. 7 €48,150.00
Stephan Martin Hohensandweg 37 €21,785.53
More recipient near this address

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.